| DURYGRAF BRISTOL-MYERS SQUIBB COMPANY (A DELAWARE CORPORATION)
1505164 24 Nov 2010 | on 15 Jun 2016 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, stroke, cancer, auto-immune diseases namely rheumatoid arthritis, multiple sclerosis, lupus, psoriatic arthritis, psoriasis, ankolysing spondylitis, Crohn's disease and ulcerative colitis, solid organ transplant rejection; pharmaceutical preparations, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, anti-inflammatories, anti-infectives, anti-psychotics, central nervous system depressants, central nervous system stimulants; pharmaceutical preparations for the treatment of the respiratory system. | | | DURYGRAF BRISTOL-MYERS SQUIBB COMPANY
(A DELAWARE CORPORATION)
1239123 30 Nov 2004 | on 22 Dec 2010 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, stroke, cancer, auto-immune diseases namely rheumatoid arthritis, multiple sclerosis, lupus, psoriatic arthritis, psoriasis, ankolysing spondylitis, Crohn's disease and ulcerative colitis, solid organ transplant rejection; pharmaceutical preparations, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, anti-inflammatories, anti-infectives, anti-psychotics, central nervous system depressants, central nervous system stimulants; pharmaceutical preparations for the treatment of the respiratory system. | | 
